Cargando…

Effects of dupilumab treatment on patch test reactions: A retrospective evaluation

Detalles Bibliográficos
Autores principales:	de Wijs, Linde E. M., van der Waa, José D., Nijsten, Tamar, Silverberg, Jonathan I., Kunkeler, Amalia C. M., Hijnen, Dirk J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362223/ https://www.ncbi.nlm.nih.gov/pubmed/33960047 http://dx.doi.org/10.1111/cea.13892

Ejemplares similares

Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series
por: de Wijs, L.E.M., et al.
Publicado: (2019)

Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient‐reported outcome measures
por: de Wijs, L.E.M., et al.
Publicado: (2021)

Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study
por: de Wijs, Linde E. M., et al.
Publicado: (2022)

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
por: Bakker, Daphne S., et al.
Publicado: (2020)

Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab
por: Zhu, Gefei Alex, et al.
Publicado: (2019)

A successful case of dupilumab treatment for severe uremic pruritus
por: Silverberg, Jonathan I., et al.
Publicado: (2019)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

Maintenance of response to dupilumab in prurigo nodularis: A retrospective cohort study
por: Selvaraj, Katina J., et al.
Publicado: (2023)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
por: Suresh, Raagini, et al.
Publicado: (2018)

Reactive perforating collagenosis successfully treated with dupilumab
por: Gil‐Lianes, Javier, et al.
Publicado: (2022)

Severe pemphigoid nodularis successfully treated with dupilumab
por: Jendoubi, Fatma, et al.
Publicado: (2022)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
por: Ayasse, Marissa, et al.
Publicado: (2020)

Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials
por: Beck, L.A., et al.
Publicado: (2020)

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study
por: Bakker, Daphne S., et al.
Publicado: (2021)

Dupilumab as a novel therapy to treat adrenergic urticaria
por: Goodman, Brian, et al.
Publicado: (2021)

Care for children with atopic dermatitis in the Netherlands during the COVID‐19 pandemic: Lessons from the first wave and implications for the future
por: Ragamin, Aviël, et al.
Publicado: (2021)

Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
por: Georgakopoulos, Jorge R., et al.
Publicado: (2021)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Usefulness of dermoscopy in the evaluation of patch test reactions()()
por: Oppermann, Kenselyn, et al.
Publicado: (2021)

Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
por: Patchinsky, Alexandra, et al.
Publicado: (2023)

Delayed local reaction at a previous injection site reaction with dupilumab
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
por: Ito, Makoto, et al.
Publicado: (2020)

Ulcerative injection-site reaction associated with dupilumab therapy
por: Phan, Michael, et al.
Publicado: (2020)

Real‐life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps
por: van der Lans, Rik Johannes Leonardus, et al.
Publicado: (2021)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
por: Bostan, Ecem, et al.
Publicado: (2021)

Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
por: Wiggins, Simmi, et al.
Publicado: (2023)

The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications
por: Woodruff, Carina M., et al.
Publicado: (2022)

Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use
por: Pacheco, Curtis S, et al.
Publicado: (2023)

New positive patch test reactions on day 7—The additional value of the day 7 patch test reading
por: van Amerongen, Cynthia C. A., et al.
Publicado: (2019)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Fixed drug eruption to nimesulide: an exuberant presentation confirmed by patch testing
por: Marques, Lidiane Pereira, et al.
Publicado: (2018)

Pilocarpine as a treatment option for dupilumab-related eye manifestations
por: Roh, Won Seok, et al.
Publicado: (2022)

Dupilumab-associated Facial Erythema Successfully Treated With Oral Ivermectin
por: Liane, Javier Gil, et al.
Publicado: (2022)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis()
por: Mitsuyama, Shinji, et al.
Publicado: (2023)

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review
por: Napolitano, Maddalena, et al.
Publicado: (2022)

A case of Grover disease treated with Dupilumab: Just serendipity or a future perspective?
por: Barei, Francesca, et al.
Publicado: (2022)

The role of patch testing in non-immediate drug hypersensitivity reactions
por: Darlenski, Razvigor, et al.
Publicado: (2015)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
por: Jang, Dong Hyek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37lrqdsvlv210vu4rv4v0tljla